PAAS Intervention for Adolescent Risky Behaviors

N/A

Waitlist Available

Led By Uma Rao, MD

Research Sponsored by University of California, Irvine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Must not have

Subject is on medication(s) that affects the central nervous system

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months post-intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial will test how an intervention program affects different regions of the brain in order to better prevent or reduce risky behaviors among African-American youth, who are highly vulnerable to the consequences of such behavior.

Who is the study for?

This trial is for African-American adolescents who can speak and read English, are willing to participate in a 6-week program called PAAS with their guardian, and pass MRI safety checks. It's not for those who are pregnant, claustrophobic, have metal implants, used alcohol or drugs recently, have major medical issues like neurological disorders, take CNS-affecting meds or have clinical-level behavioral problems.

What is being tested?

The study tests the PAAS intervention program designed to reduce risky behaviors among African-American youth. Researchers will look at how this program influences brain regions associated with risk-taking behavior by using MRI scans before and after the program.

What are the potential side effects?

Since this trial involves an educational intervention rather than medication, traditional side effects aren't expected. However, participants may experience discomfort from sitting still during MRI scans or discussing sensitive topics during the PAAS sessions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am taking medication that affects my brain or nerves.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Changes in fronto-striatal functional connectivity

Secondary study objectives

Changes in cognitive regulation

Changes in emotional regulation

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Pathways for African-Americans' SuccessExperimental Treatment1 Intervention

Subjects will complete a 6-week Pathways for African-Americans' Success (PAAS) intervention. This is a weekly, 1.5 hour/session, family intervention for 6 weeks.

Group II: Wait-listActive Control1 Intervention

Subjects will be on waiting list for active intervention and will receive the PAAS intervention at the end of the study (same as active intervention).

0 / 1Eligibility criteria met